Related by context. Frequent words. (Click for all words.) 68 liver transplant recipients 66 mycophenolate mofetil 66 heavily pretreated 65 coinfected 65 interferon therapy 64 concomitant medications 64 T2DM 64 neuropsychiatric symptoms 64 KRAS mutations 63 breast carcinoma 63 tipranavir 63 multivariate analyzes 62 NHANES III 62 elotuzumab 62 tumor lysis syndrome 62 thrombophilia 62 neoadjuvant therapy 62 subgroup analyzes 62 pertuzumab 62 cabazitaxel 62 univariate analysis 62 Natalizumab 62 EGFR mutations 62 neoadjuvant 62 antihypertensive therapy 61 HER2 positive metastatic breast 61 chlorambucil 61 HCV genotype 1 61 platelet reactivity 61 immunosuppressive agents 61 % CI #.#-#.# [007] 61 ischemic cardiomyopathy 61 genetic polymorphisms 61 olmesartan 61 virologic failure 61 mRCC 61 pheochromocytoma 61 androgen deprivation 61 irbesartan 61 HCV genotype 61 ximelagatran 61 superficial bladder cancer 61 Secondary endpoints 61 tirofiban 61 mg kg dose 61 HSCT 61 ocrelizumab 61 peginterferon 60 placebo controlled clinical trials 60 virologic 60 COPAXONE R 60 alteplase 60 voriconazole 60 glitazones 60 elevated LDL cholesterol 60 lipid lowering therapy 60 interferon alfa 60 heavily pretreated patients 60 azacitidine 60 tigecycline 60 primary hypercholesterolemia 60 subanalysis 60 iclaprim 60 docetaxel chemotherapy 60 prospectively defined 60 metastatic castration resistant 60 reperfusion therapy 60 therapeutic regimens 60 carcinoid tumors 60 % CI #.#-#.# [006] 60 statistically significant p = 60 atherothrombosis 60 TYGACIL 60 cardiovascular morbidity 60 decitabine 60 neoadjuvant chemotherapy 60 H pylori 60 elevated CRP 60 thromboprophylaxis 60 glatiramer acetate 60 sunitinib 60 comorbid conditions 60 stable angina 60 renal insufficiency 60 acute coronary syndromes ACS 60 forodesine 60 angiotensin converting enzyme inhibitors 60 Solid Tumors 60 relapsed refractory multiple myeloma 60 cholangiocarcinoma 60 Chronic Hepatitis C 59 PREZISTA r 59 darunavir 59 Response Evaluation Criteria 59 hyperglycaemia 59 renal toxicity 59 PCa 59 REVLIMID ® 59 myeloproliferative disorders 59 chronic HCV infection 59 thromboembolic events